US 11517584
RNAi agents for Hepatitis B virus infection
granted A61KA61K31/675A61K31/7088
Quick answer
US patent 11517584 (RNAi agents for Hepatitis B virus infection) held by Arrowhead Pharmaceuticals, Inc. expires Mon Dec 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Arrowhead Pharmaceuticals, Inc.
- Grant date
- Tue Dec 06 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 58
- CPC classes
- A61K, A61K31/675, A61K31/7088, A61K31/7105, A61K9/0019